Nebenwirkungen · Buvidal
Buvidal 64 mg prolonged-release solution for injection Buvidal 96 mg prolonged-release solution for injection Buvidal 128 mg prolonged-release solution for injection Buvidal 160 mg prolonged-release solution for injection · Abschnitt 4.8 · PDF-Seite 27
HOS-140348 · Präparat HOS-098498
Gastrointestinal Nausea Constipation disorders Vomiting Abdominal pain Flatulence Dyspepsia Dry mouth Diarrhoea Gastrointestinal disorder Hepatobiliary Alanine disorders aminotransferase increased Aspartate aminotransferase increased Hepatic enzymes increased Skin and Rash Rash macular Erythema subcutaneous tissue Pruritus disorders Urticaria Musculoskeletal and Arthralgia connective tissue Back pain disorders Myalgia Muscle spasms Neck pain Bone pain Renal and urinary Urinary retention disorders Reproductive Dysmenorrhoea system and breast disorders General disorders Hyperhidrosis Injection site pain Injection site Injection site and administration Drug Injection site pruritus inflammation abscess site conditions withdrawal Injection site Injection site Injection site syndrome erythema bruising ulceration Pain Injection site swelling Injection site Injection site Injection site reaction urticaria necrosis Injection site induration Injection site mass Oedema peripheral Asthenia Malaise Pyrexia Chills Neonatal withdrawal syndrome Chest pain Investigations Abnormal liver function tests Injury, poisoning Procedural and procedural dizziness complications
Originalpassage; keine automatisch abgeleitete Schwere, Häufigkeit oder Kausalität. Auch verneinte Befunde und nicht untersuchte Kombinationen bleiben sichtbar.
Vollständigen Kontext in der EMA-Fachinformation lesen →Quellennachweis
Version 2025-03-21T17:42:00Z · SHA-256 1ad9ce13109b545d01c45ffd56cec5dc90c2b7294f4e2ae1f7e5e985c1a064eb · Passage 6da4257da19ad9af7940f6ca1f4165cfb3b5f87f156c2120cea6a5d01eac960c · Zeichen 2898–6313 im Abschnitt